To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of…
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Opportunity
-
- Comprehensive and Rapid Response to NIAID Research Programs Pre-Solicitation · Posted Jun 16, 2020
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20814, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,000 | |
| Original award | $2,000 |
About this award
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $2,000 firm fixed price delivery order against an unspecified contract vehicle to Lovelace Biomedical Research Institute. The delivery order is for comprehensive and rapid response services to support NIAID's research programs over a one year period from September 2021 through August 2022. The place of performance will be in Bethesda, Maryland. No set aside designation or subcontractors were indicated. NIAID conducts and supports research on infectious, immunologic, and allergic diseases to better understand, treat, and ultimately prevent these conditions. This delivery order will provide flexible support services that enable NIAID to respond quickly to emerging infectious disease needs and advance its research portfolio.
Description
To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of availability of these fiscal year funds.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to Lovelace Biomedical Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2021.
How much is contract 75N93021F00001 worth?
The government has obligated $0 on 75N93021F00001.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93021D00031, an indefinite delivery contract.
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award